Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001225208-17-009615
Filing Date
2017-05-12
Accepted
2017-05-12 16:58:07
Documents
1
Period of Report
2017-05-12

Document Format Files

Seq Description Document Type Size
1 doc4.html 4  
1 doc4.xml 4 7038
  Complete submission text file 0001225208-17-009615.txt   8519
Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 908-740-4000
Merck & Co., Inc. (Issuer) CIK: 0000310158 (see all company filings)

EIN.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 5400 LEGACY DR H3 3E 35 PLANO TX 75024
Business Address
KIDDER C ROBERT (Reporting) CIK: 0001179703 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-06571 | Film No.: 17839585